Randomized study to compare Paclitaxel/Topotecan vs. Cisplatin/Topotecan in patients with recurrent cervical cancer - AGO-Cervix-1 study

被引：0
|
作者：
Thiel, F. C. [1 ]
Hilpert, F. [2 ]
Rein, D. [3 ]
Liebrich, C. [4 ]
Fasching, P. A. [5 ]
Beckmann, M. W. [5 ]
机构：
[1] Univ Frauenklin Erlangen, Erlangen, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Kiel, Germany
[3] Univ Frauenklin, Dusseldorf, Germany
[4] Klinikum Stadt Wolfsburg, Frauenklin, Wolfsburg, Germany
[5] Univ Klinikums Erlangen, Frauenklin, Erlangen, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷
关键词：
cervical cancer; paclitaxel; recurrent; topotecan;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [41] A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study
    Armstrong, Deborah K.
    Bookman, Michael A.
    McGuire, William
    Bristow, Robert E.
    Schilder, Jeanne M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 667 - 671
  • [42] A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Mullerian tumors
    Penson, RT
    Supko, JG
    Seiden, MV
    Fuller, AF
    Berkowitz, RS
    Goodman, A
    Campos, SM
    MacNeill, KM
    Cook, S
    Matulonis, UA
    CANCER, 2001, 92 (05) : 1156 - 1167
  • [43] Cisplatin-topotecan-paclitaxel weekly administration in ovarian (OC) and small cell lung cancer (SCLC). A phase I study
    Frasci, G
    Comella, P
    Carteni, G
    Panza, N
    Guida, T
    Nicolella, GP
    Lombardi, R
    Pacilio, C
    Gravina, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 70
  • [44] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
    Bolis, Giorgio
    Scarfone, Giovanna
    Raspagliesi, Francesco
    Mangili, Giorgia
    Danese, Saverio
    Scollo, Paolo
    Lo Russo, Domenica
    Villa, Antonella
    Aimone, Paola Daniela
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912
  • [45] Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
    Sun, Wenze
    Wang, Tao
    Shi, Fan
    Wang, Jiquan
    Wang, Juan
    Hui, Beina
    Zhang, Yingbing
    Lu, Jinli
    Chen, Hongwei
    Liu, Zi
    BMC CANCER, 2015, 15
  • [46] Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
    Wenze Sun
    Tao Wang
    Fan Shi
    Jiquan Wang
    Juan Wang
    Beina Hui
    Yingbing Zhang
    Jinli Lu
    Hongwei Chen
    Zi Liu
    BMC Cancer, 15
  • [47] Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: A Cancer and Leukemia Group B study
    Lilenbaum, RC
    Miller, AA
    Batist, G
    Bernard, S
    Hollis, DR
    Rosner, GL
    Egorin, MJ
    Schilsky, RL
    Ratain, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) : 3302 - 3309
  • [48] Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
    Matthew A Beldner
    Carol A Sherman
    Mark R Green
    Elizabeth Garrett-Mayer
    Uzair Chaudhary
    Mario L Meyer
    Andrew S Kraft
    Alberto J Montero
    BMC Cancer, 7
  • [49] Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study
    Syrios, John
    Kouroussis, Charalambos
    Kotsakis, Athanasios
    Kentepozidis, Nikolaos
    Kontopodis, Emmanouil
    Kalbakis, Kostas
    Vardakis, Nikolaos
    Hatzidaki, Dora
    Polyzos, Aris
    Georgoulias, Vassilis
    MINERVA GINECOLOGICA, 2019, 71 (03): : 182 - 190
  • [50] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.
    Guppy, AE
    Nelstrop, A
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2002, 86 : S44 - S44
12345